Found: 9
Select item for more details and to access through your institution.
Complications and Risk Factors in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1977, doi. 10.3390/cancers16111977
- By:
- Publication type:
- Article
Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1789, doi. 10.3390/cancers16101789
- By:
- Publication type:
- Article
Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy: Systematic Review of the Literature.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4486, doi. 10.3390/cancers15184486
- By:
- Publication type:
- Article
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 633, doi. 10.1093/oncolo/oyad076
- By:
- Publication type:
- Article
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1643, doi. 10.3390/cancers15061643
- By:
- Publication type:
- Article
Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 6, p. 720, doi. 10.1080/0284186X.2022.2066983
- By:
- Publication type:
- Article
Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6825, doi. 10.3390/ijms22136825
- By:
- Publication type:
- Article
Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 527, doi. 10.3390/cancers13030527
- By:
- Publication type:
- Article
Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
- Published in:
- Oncology, 2017, v. 93, n. 3, p. 183, doi. 10.1159/000475758
- By:
- Publication type:
- Article